Efficacy of Pana and Pratimarsha Nasya of Guduchyadi Ghrita in themanagement of Mild Neurocognitive Disorder: A single arm open labeled clinical trial

Institute of Teaching and Research in Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月1日

试验速览

暂无简介。

•1) Subjects irrespective of gender, fulfilling the criteria of Mild Neurocognitive Disorder as per DSM V.
•2) Age group â?? 40 - 70 years
•3) Montreal Cognitive Assessment scale [MoCA] (18 to 25)
•4) Patients willing to accept participation in the clinical trial.

•1) Age below 40 years and above 70 years.
•2) Subjects with major depression or other psychiatric disorders or currently undergoing treatment for depression.
•3) Use of psychoactive medication that would affect the subjectâ??s ability to reliably perform on neurocognitive testing.
•4) Subjects with Malignant disease, HIV or serious infection.
•5) Subjects with Cardiovascular, Renal or Hepatic disorder, Thyroid dysfunction.
•6)subjects with Stage II HTN or above (Blood Pressure >160/100 mm of Hg), Diabetes (FBS >200 mg/dl), Dyslipidemia (Severe Hypertriglyceridemia,TG >500 mg/dl and /or, LDL >190 mg/dl)
•7) Subjects who have decline in cognitive functions as a result of surgery and trauma.
•8) Visual/auditory impairment that would preclude the participant from participating in or cooperating with the protocol.
•9) Pregnant women and lactating mothers.
•10) Patient with alcohol abuse.
•11) Subjects who are not able to read, write and comprehend Hindi language properly for comprehending the assessment tests.

发起方

Institute of Teaching and Research in Ayurveda